Research Topic: immunology

Biochemical characteristics of extracts from proallergenic microfungi Erysiphe palczewskii and Erysiphe convolvuli

Researchers studied two types of fungi that cause powdery mildew on plants and can trigger allergies in people who breathe in their spores. They discovered that these fungi contain proteins that act as allergens, including special proteins that help fungi survive stress. The fungi also contain high levels of linoleic acid, a fatty acid that can increase inflammation in the body. This research helps scientists understand why these fungi can cause allergic reactions and could help develop better diagnostic tools for fungal allergies.

Read More »

An Atypical Presentation of Allergic Bronchopulmonary Aspergillosis

A 57-year-old man without prior lung problems developed a persistent cough and breathing difficulties that didn’t respond to antibiotics. Imaging showed his lung had collapsed and fluid had accumulated around it, raising concerns about cancer. However, bronchoscopy revealed the collapse was caused by thick mucus plugs filled with Aspergillus fungus rather than cancer. After treatment with antifungal medication and steroids, the patient fully recovered with his lung re-expanding and fluid resolving.

Read More »

Pathogenic mucorales: Deciphering their cell wall polysaccharidome and immunostimulatory potential

Mucormycosis is a serious fungal infection that primarily affects people with weak immune systems and carries high mortality rates. Researchers studied three common mucormycosis-causing fungi to understand how their outer cell layers interact with the human immune system. They found that all three fungi trigger strong inflammatory responses, which may explain why the disease is so damaging. This research helps us better understand how these infections work and could lead to improved treatments or vaccines.

Read More »

Condition-dependent effects of Elexacaftor/Tezacaftor/Ivacaftor (Trikafta) on Aspergillus fumigatus growth

This study examines how Trikafta, a new cystic fibrosis medication, affects a common fungal lung infection (Aspergillus fumigatus). The researchers found that Trikafta doesn’t directly kill the fungus but does make it more susceptible to antifungal drugs and improves lung clearance. Surprisingly, at high concentrations, the medication actually reduced the immune response against the fungus in immune cells, suggesting the need for careful monitoring of patients on this therapy.

Read More »

Glycan microarray analysis of Candida-related antibodies in human and mice sera guides biomarker discovery and vaccine development

Researchers used a special microarray technology to identify immune responses in blood samples from people infected with Candida yeast. They found that early infections trigger antibodies against certain sugar structures, while later infections produce different antibodies. Three specific sugar molecules showed promise as markers for diagnostic tests and vaccine development against dangerous yeast infections.

Read More »

PTP1B deficiency in myeloid cells increases susceptibility to Candida albicans systemic infection by modulating antifungal immunity

This research shows that a protein called PTP1B plays an important role in protecting the body against dangerous yeast infections caused by Candida albicans. When this protein is missing from immune cells, mice become much more susceptible to severe fungal infections. The study found that PTP1B helps immune cells called macrophages and neutrophils kill fungi effectively, and when it’s absent, these immune cells work poorly. This discovery suggests that targeting PTP1B could be a new way to help patients fight off serious fungal infections.

Read More »

Eumelanin Detection in Melanized Focal Changes but Not in Red Focal Changes on Atlantic Salmon (Salmo salar) Fillets

Farmed Atlantic salmon sometimes develop unsightly black and red spots that reduce market value. Researchers analyzed these discolored areas and found that the black spots contain a type of melanin pigment (eumelanin) produced by immune cells called melanomacrophages. The red spots contain different compounds formed from oxidized proteins rather than true melanin. Understanding the chemical differences between these two types of spots could help salmon farmers develop better prevention strategies.

Read More »

The C-type lectin receptor Dcir (Clec4a2) restrains Aspergillus fumigatus elimination by limiting the degranulatory activity of neutrophils

This study reveals that a receptor called Dcir on immune cells called neutrophils actually prevents effective killing of the fungus Aspergillus fumigatus by limiting the release of antibacterial granules. When researchers removed Dcir from mice, their neutrophils became more effective at fighting the fungal infection. This suggests that blocking Dcir might help patients with fungal respiratory infections clear the pathogen more effectively.

Read More »

Phospholipase PlcH is involved in the secretion of cell wall glycoproteins and contributes to the host immune response of Aspergillus fumigatus

Researchers discovered that an enzyme called PlcH helps a dangerous mold called Aspergillus fumigatus release protective proteins into its cell wall. These proteins help the fungus survive and evade the immune system. When scientists removed the gene for PlcH, the fungus became weaker and more vulnerable to both antifungal drugs and immune cells, suggesting PlcH could be a target for new antifungal treatments.

Read More »

Abundant Yet Aberrant T Helper Cell Responses to Candida albicans Underlie Mucosal Candidiasis in Humans and Mice

Researchers studied how the immune system fights Candida albicans fungal infections. They found that a specific type of immune cell called Th17 cells is absolutely essential for controlling these infections, while other immune cells called Th2 cells actually make infections worse by blocking the protective Th17 cells. Patients with certain genetic mutations that affect how their immune system works have too many Th2 cells and not enough Th17 cells, making them vulnerable to chronic fungal infections. The study suggests that blocking a molecule called IL-4 could help restore the balance and improve patient outcomes.

Read More »
Scroll to Top